These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2863182)

  • 41. Characteristics of transmitter release at regenerating frog neuromuscular junctions.
    Dennis MJ; Miledi R
    J Physiol; 1974 Jun; 239(3):571-94. PubMed ID: 4152807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmitter secretion varies between visualized release sites at amphibian neuromuscular junctions.
    Bennett M; Jones P; Lavidis N
    Neurosci Lett; 1986 Apr; 65(3):311-5. PubMed ID: 2872629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory role of intracellular sodium ions in neurotransmitter secretion.
    Melinek R; Lev-Tov A; Meiri H; Erulkar SD; Rahamimoff R
    Isr J Med Sci; 1982 Jan; 18(1):37-43. PubMed ID: 6121773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium-independent regulation of transmitter release at the frog neuromuscular junction.
    Kijima H; Tanabe N; Sato J; Kijima S
    Ann N Y Acad Sci; 1993 Dec; 707():443-6. PubMed ID: 9137590
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of trifluoperazine and promethazine on the release of transmitter quanta at the mouse neuromuscular junction.
    Nishimura M; Komatsu R; Taquahashi Y; Shimizu Y; Satoh E
    J Peripher Nerv Syst; 1998; 3(2):111-5. PubMed ID: 10959244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transmitter release during repetitive stimulation: selective changes produced by Sr2+ and Ba2+.
    Zengel JE; Magleby KL
    Science; 1977 Jul; 197(4298):67-9. PubMed ID: 17160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sphingosine 1-phosphate enhances spontaneous transmitter release at the frog neuromuscular junction.
    Brailoiu E; Cooper RL; Dun NJ
    Br J Pharmacol; 2002 Aug; 136(8):1093-7. PubMed ID: 12163341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transmitter release from normal and degenerating locust motor nerve terminals.
    Hodgkiss JP; Usherwood PN
    J Physiol; 1978 Dec; 285():113-28. PubMed ID: 217984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
    Sellin LC; Thesleff S; Dasgupta BR
    Acta Physiol Scand; 1983; 119(2):127-33. PubMed ID: 6140815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Control of quantal transmitter release at frog's motor nerve terminals. II. Modulation by de- or hyperpolarizing pulses.
    Dudel J
    Pflugers Arch; 1984 Nov; 402(3):235-43. PubMed ID: 6151643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of pH changes on the frequency of miniature end-plate potentials at the frog neuromuscular junction.
    Cohen I; Van Der Kloot W
    J Physiol; 1976 Nov; 262(2):401-14. PubMed ID: 11340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evolution in time of transmitter release at frog neuromuscular junction].
    Vautrin J; Mambrini J
    C R Seances Acad Sci D; 1979 Dec; 289(15):1175-8. PubMed ID: 44854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Muscarinic agonists do not alter the process of spontaneous quantum secretion of the mediator from motor nerve endings in the frog].
    Nikol'skiĭ EE; Bukharaeva EA
    Biull Eksp Biol Med; 1987 Feb; 103(2):183-5. PubMed ID: 2880613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenytoin and transmitter release at the neuromuscular junction of the frog.
    Yaari Y; Pincus JH; Argov Z
    Brain Res; 1979 Jan; 160(3):479-87. PubMed ID: 33744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of quantal transmitter release at frog's motor nerve terminals. I. Dependence on amplitude and duration of depolarization.
    Dudel J
    Pflugers Arch; 1984 Nov; 402(3):225-34. PubMed ID: 6151642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of tetraphenylboron on spontaneous transmitter release at the frog neuromuscular junction.
    Marshall IG; Parsons RL
    Br J Pharmacol; 1975 Jul; 54(3):333-8. PubMed ID: 240472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adrenocorticotropic hormone causes long-lasting potentiation of transmitter release from frog motor nerve terminals.
    Johnston MF; Kravitz EA; Meiri H; Rahamimoff R
    Science; 1983 Jun; 220(4601):1071-2. PubMed ID: 6133353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can presynaptic depolarization release transmitter without calcium influx?
    Zucker RS; Landò L; Fogelson A
    J Physiol (Paris); 1986; 81(4):237-45. PubMed ID: 2883310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals.
    Lundh H; Thesleff S
    Eur J Pharmacol; 1977 Apr; 42(4):411-2. PubMed ID: 15849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.